Medicalsystem Biotechnology Co., Ltd

Equities

300439

CNE100001Z25

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
10.07 ^CNY	+0.60%		-.--%	-13.26%

05-27	Medicalsystem Biotechnology Co., Ltd Approves Cash Dividend for the Year 2023	CI
05-22	MedicalSystem Biotechnology Gets Registration Certificates for Two Products	MT

Liu Jianfeng agreed to acquire 23% stake in Hunan Pinxin Bioengineering Co., Ltd. from Medicalsystem Biotechnology Co.,Ltd for CNY 22.4 million.

August 13, 2021

Liu Jianfeng agreed to acquire 23% stake in Hunan Pinxin Bioengineering Co., Ltd. from Medicalsystem Biotechnology Co.,Ltd (SZSE:300439) for CNY 22.4 million on August 12, 2021. Hunan Pinxin Bioengineering Co., Ltd. reported total assets of CNY 24.8444 million and net assets of CNY 10.7941 million as of June 30, 2021.

Latest news about Medicalsystem Biotechnology Co., Ltd

Medicalsystem Biotechnology Co., Ltd Approves Cash Dividend for the Year 2023	05-27	CI
MedicalSystem Biotechnology Gets Registration Certificates for Two Products	05-22	MT
Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-23	CI
Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	04-18	CI
MedicalSystem Biotechnology Gets Nod to Market Fibrinogen Detection Kit	03-22	MT
Medicalsystem Biotechnology Co., Ltd Announces Board Appointments	12-18	CI
Medicalsystem Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23	CI
MedicalSystem Biotechnology Registers Thyroid Protein Detection Kit	04/09/23	MT
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	18/08/23	CI
Ningbo Ruiheyuan Biotechnology Co., Ltd. announced that it expects to receive CNY 192 million in funding from Medicalsystem Biotechnology Co., Ltd	17/08/23	CI
Medicalsystem Biotechnology Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 16 June 2023	09/06/23	CI
Medicalsystem Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2022	22/05/23	CI
MedicalSystem Biotechnology Registers Two New Medical Devices	22/05/23	MT
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Medicalsystem Biotechnology Co., Ltd. Approves Final Dividend for 2022	26/04/23	CI
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/04/23	CI
Chen Chaohong completed the acquisition of a 5% stake in Medicalsystem Biotechnology Co., Ltd. from Zou Bingde.	01/03/23	CI
MedicalSystem Biotechnology Registers Two New Medical Devices in China	16/02/23	MT
MedicalSystem Biotechnology Registers Two New Medical Devices	01/02/23	MT
Chen Chaohong signed the Share Transfer Agreement to acquire 5% stake in Medicalsystem Biotechnology Co., Ltd. from Zou Bingde for approximately CNY 180 million	23/12/22	CI
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/10/22	CI
Medicalsystem Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
Medicalsystem Biotechnology Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 8, 2022	31/05/22	CI
Medicalsystem Biotechnology Co., Ltd. Approves Cash Dividend for 2021	18/05/22	CI
Medicalsystem Biotechnology Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22	CI

Chart Medicalsystem Biotechnology Co., Ltd

Duration

Period

Chart Medicalsystem Biotechnology Co., Ltd

More charts

Company Profile

MedicalSystem Biotechnology Co., Ltd. is a China-based company engaged in the research and development, manufacture and distribution of in-vitro diagnostic products. The Companyâs in-vitro diagnostic products include in-vitro diagnostic reagent and in-vitro diagnostic instrument. In addition, the Company is also involved in the provision of third-party medical diagnosis services, as well as the production and distribution of reagent raw materials. The Company mainly operates businesses in domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

18/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
MEDICALSYSTEM BIOTECHNOLOGY CO., LTD	-13.26%	534M
BIOMÉRIEUX	-3.43%	12.45B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.17%	8.22B
DIASORIN S.P.A.	+6.11%	5.72B
LANTHEUS HOLDINGS, INC.	+31.98%	5.67B
AUTOBIO DIAGNOSTICS CO., LTD.	-10.03%	4.11B
10X GENOMICS, INC.	-59.94%	2.68B
ANDON HEALTH CO., LTD.	+11.23%	2.68B
VITROLIFE AB	-5.14%	2.37B
MYRIAD GENETICS, INC.	+18.91%	2.06B

Diagnostic & Testing Substances